An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo

被引:63
作者
Lupu, Catalin M.
Eisenbach, Christoph
Kuefner, Michael A.
Schmidt, Jan
Lupu, Alaviana D.
Stremmel, Wolfgang
Encke, Jens
机构
[1] Univ Heidelberg, Dept Gastroenterol, D-69120 Heidelberg, Germany
[2] Univ Heidelberg, Dept Gen Surg, D-69120 Heidelberg, Germany
[3] Univ Heidelberg, Dept Haematol, D-69120 Heidelberg, Germany
关键词
animal model; colon cancer; costimulatory molecule;
D O I
10.1016/j.gassur.2006.02.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We established an orthotopic animal model of colon cancer in mice and applied this model to study the antitumor effects of B7-H3, the newest member of the B7 family of costimulatory molecules. Colon-26 murine colon adenocarcinoma cells were inoculated into the cecal subserosum of mice to induce colon tumor growth. The tumor growth rate and the survival time of the mice were observed. A stable B7-H3 transfected Colon-26 cell line was established and the immunogenic effect was investigated. All mice implanted with wild-type tumor cells had tumor growth in the colon and died. The mean survival rate was 23 days. Mice implanted with C26-B7-H3 had a significantly prolonged survival time of 38 days. Our data suggest that B7-H3 exerts an antitumor effect on adenocarcinoma of the colon and may be considered as an adjuvant immunotherapy in the treatment of colon cancers. Our orthotopic animal model of colon cancer in mice could be applied to in vivo experimental studies of colon cancer.
引用
收藏
页码:635 / 645
页数:11
相关论文
共 31 条
[1]
Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies [J].
Bankert, RB ;
Egilmez, NK ;
Hess, SD .
TRENDS IN IMMUNOLOGY, 2001, 22 (07) :386-393
[2]
CONSTITUTIVE EXPRESSION OF B7 RESTORES IMMUNOGENICITY OF TUMOR-CELLS EXPRESSING TRUNCATED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES [J].
BASKAR, S ;
OSTRANDROSENBERG, S ;
NABAVI, N ;
NADLER, LM ;
FREEMAN, GJ ;
GLIMCHER, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5687-5690
[3]
A NEW ANIMAL-MODEL FOR HUMAN-COLON CANCER METASTASIS [J].
BRESALIER, RS ;
RAPER, SE ;
HUJANEN, ES ;
KIM, YS .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (05) :625-630
[4]
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production [J].
Chapoval, AI ;
Ni, J ;
Lau, JS ;
Wilcox, RA ;
Flies, DB ;
Liu, D ;
Dong, HD ;
Sica, GL ;
Zhu, GF ;
Tamada, K ;
Chen, LP .
NATURE IMMUNOLOGY, 2001, 2 (03) :269-274
[5]
COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[6]
ORTHOTOPIC IMPLANTATION OF HUMAN COLON CARCINOMAS INTO NUDE-MICE PROVIDES A VALUABLE MODEL FOR THE BIOLOGY AND THERAPY OF METASTASIS [J].
FIDLER, IJ .
CANCER AND METASTASIS REVIEWS, 1991, 10 (03) :229-243
[7]
Cancer vaccines: Between the idea and the reality [J].
Finn, OJ .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (08) :630-641
[8]
Effect of E7010 on liver metastasis and life span of syngeneic C57BL/6 mice bearing orthotopically transplanted murine Colon 38 tumor [J].
Funahashi, Y ;
Koyanagi, N ;
Kitoh, K .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (02) :179-184
[9]
GIAVAZZI R, 1986, CANCER RES, V46, P1928
[10]
GOLDROSEN MH, 1980, CANCER, V45, P1223, DOI 10.1002/1097-0142(19800315)45:5+<1223::AID-CNCR2820451330>3.0.CO